ASMB
Assembly Biosciences, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Assembly Biosciences, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Fund move
Fund move
No thesis.
Assembly Biosciences, Inc.
20.16
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Gilead SciencesGilead Sciences | $136.8M | 26.48% | +10.47% | |
| 2 | Farallon Capital ManagementFarallon | $44.1M | 8.54% | new | |
| 3 | Paradigm Biocapital AdvisorsParadigm Biocapital | $42.7M | 8.27% | +133.56% | |
| 4 | Commodore CapitalCommodore Capital | $38.9M | 7.53% | +41.50% | |
| 5 | RA Capital ManagementRA Capital Management | $28.0M | 5.43% | 0.00% | |
| 6 | Jupiter TopcoJupiter Topco | $23.4M | 4.52% | — | |
| 7 | BlackRockBlackRockindex-like | $21.1M | 4.08% | +278.22% | |
| 8 | Parkman Healthcare PartnersParkman Healthcare Partners | $19.8M | 3.84% | +75.37% | |
| 9 | Vanguard Capital ManagementVanguardindex-like | $15.4M | 2.97% | +13.97% | |
| 10 | Point72 Asset ManagementPoint72 | $12.7M | 2.45% | +33.85% | |
| 11 | Seven Fleet Capital ManagementSeven Fleet | $11.9M | 2.30% | +671.45% | |
| 12 | Millennium ManagementMillennium | $8.2M | 1.59% | +27.89% | |
| 13 | Geode Capital ManagementGeodeindex-like | $7.7M | 1.49% | +110.89% | |
| 14 | Schonfeld Strategic AdvisorsSchonfeld Strategic | $6.7M | 1.29% | +100.96% | |
| 15 | Ameriprise FinancialAmeriprise Financial | $6.3M | 1.22% | new | |
| 16 | DV EquitiesDV Equities | $6.2M | 1.20% | new | |
| 17 | Standard Life AberdeenStandard Life Aberdeen | $5.7M | 1.10% | new | |
| 18 | Affinity Asset AdvisorsAffinity Asset | $5.2M | 1.01% | new | |
| 19 | B GroupB Group | $4.8M | 0.93% | 0.00% | |
| 20 | State StreetState Streetindex-like | $4.7M | 0.91% | +203.29% | |
| 21 | StemPoint CapitalStemPoint Capital | $4.7M | 0.91% | −8.12% | |
| 22 | Squadron Capital ManagementSquadron | $4.4M | 0.85% | new | |
| 23 | Woodline PartnersWoodline Partners | $4.1M | 0.80% | new | |
| 24 | Driehaus Capital ManagementDriehaus | $4.1M | 0.80% | new | |
| 25 | Ally Bridge Group (NY)Ally Bridge Group (NY) | $3.8M | 0.74% | new |
93 managers report $516.5M of Assembly Biosciences on form 13F for the quarter ended Jun 30 '26. 14 of them hold 80% of it; Gilead Sciences is largest at 26.48%.
Linked news
No implied move.
No implied move.
Expected move
No implied move.